Saturday, October 31, 2026

NASDAQ 100 Is 10% Up In The Last 21 Sessions

ViaNews Editorial Team

December 1, 2023

NASDAQ 100 Is 10% Up In The Last 21 Sessions

(VIANEWS) - NASDAQ 100 (NDX) has been up by 10.39% for the last 21 sessions. At 19:11 EST on Thursday, 30 November, NASDAQ 100 (NDX) is $15,907.69.

Volume

Today's last reported volume for NASDAQ 100 is 130816768, 94.8% below its average volume of 2519871129.15.

Regarding NASDAQ 100's yearly highs and lows, it's 49.07% up from its 52-week low and 1.6% down from its 52-week high.

Volatility

NASDAQ 100's last week, last month's, and last quarter's current intraday variation average was a negative 0.02%, a positive 0.52%, and a positive 0.82%, respectively.

NASDAQ 100's highest amplitude of average volatility was 0.17% (last week), 0.72% (last month), and 0.82% (last quarter), respectively.

Previous days news about NASDAQ 100 (NDX)

  • Nasdaq 100 forecast: hovers - 28 November 2023. According to DailyForex on Tuesday, 28 November, "I have no interest in shorting the NASDAQ 100 anytime soon, as it is clear that traders continue to look for value opportunities every time it pulls back. "

News about

  • According to FXStreet on Tuesday, 28 November, "Heading into the European trading, however, there seems to be a slight improvement in the market mood, reflective of a modest uptick in the US S&P 500 futures. "
  • According to Zacks on Tuesday, 28 November, "In the first half of 2023, U.S. small-cap stocks showed decent trends but lagged the S&P 500 (up about 16%) and Nasdaq Composite (up about 31.7%). ", "But Wall Street has seen a surge in small-cap stocks lately, with the Russell 2000 index climbing over 9.3% in the past one month versus 9.2% gains in the S&P 500 and 11.4% uptick in the Nasdaq Composite. "
  • According to Zacks on Tuesday, 28 November, "Its current dividend yield is 3.23% compared with the Zacks S&P 500 composite's average of 1.69%."
  • According to MarketWatch on Tuesday, 28 November, "U.S. stocks opened mostly lower Tuesday, with the S&P 500 heading for a potential back-to-back decline, as investors await remarks from Federal Reserve officials.", "The Dow Jones Industrial Average DJIA was up less than 0.1% soon after the opening bell, while the S&P 500 SPX slipped 0.1% and the Nasdaq Composite COMP shed 0.1%, according to FactSet data, at last check. "

More news about NASDAQ 100 (NDX).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com